Caricamento...
Expression of EZH2 is associated with poor outcome in colorectal cancer
Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been w...
Salvato in:
| Pubblicato in: | Oncol Lett |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5778885/ https://ncbi.nlm.nih.gov/pubmed/29435024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7647 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|